Works matching IS 11727047 AND DT 2021 AND VI 35 AND IP 11


Results: 7
    1
    2
    3
    4
    5
    6
    7

    Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.

    Published in:
    CNS Drugs, 2021, v. 35, n. 11, p. 1217, doi. 10.1007/s40263-021-00860-7
    By:
    • Sharmin, Sifat;
    • Lefort, Mathilde;
    • Andersen, Johanna Balslev;
    • Leray, Emmanuelle;
    • Horakova, Dana;
    • Havrdova, Eva Kubala;
    • Alroughani, Raed;
    • Izquierdo, Guillermo;
    • Ozakbas, Serkan;
    • Patti, Francesco;
    • Onofrj, Marco;
    • Lugaresi, Alessandra;
    • Terzi, Murat;
    • Grammond, Pierre;
    • Grand'Maison, Francois;
    • Yamout, Bassem;
    • Prat, Alexandre;
    • Girard, Marc;
    • Duquette, Pierre;
    • Boz, Cavit
    Publication type:
    Article